This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Katsuaki Fujiwara: Innovator in Anticancer Compounds
Introduction
Katsuaki Fujiwara is a notable inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. With a total of 2 patents, his work continues to impact the medical community.
Latest Patents
His latest patents include an α,β-unsaturated amide compound, which is designed to provide anticancer activity. This invention is represented by a specific formula, where 'A' denotes an optionally substituted heterocyclic diyl. The compound or its pharmaceutically acceptable salt is aimed at enhancing treatment options for cancer patients.
Career Highlights
Katsuaki Fujiwara is currently employed at Kyowa Kirin Co., Ltd., a company known for its commitment to innovative healthcare solutions. His work at this organization has allowed him to focus on developing new therapeutic agents that can improve patient outcomes.
Collaborations
One of his notable collaborators is Tomohiro Danjo. Their partnership has fostered a productive environment for research and development, leading to advancements in their respective fields.
Conclusion
Katsuaki Fujiwara's contributions to the field of pharmaceuticals, particularly through his patents on anticancer compounds, highlight his role as an influential inventor. His ongoing work at Kyowa Kirin Co., Ltd. continues to pave the way for innovative treatments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile